Global Blood Ketone Meter Market to reach USD 440.2 million by 2027.Global Blood Ketone Meter Market is valued approximately USD 279.6 million in 2020 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2021-2027. Ketones are developed by the body when fats are broken down, a process known as ketosis. When there is a lack of sugar in the cells owing to a low amount of insulin, the body generates ketones. As a result, the body begins to break down fat in order to produce ketones as a substitute for sugar. Ketosis also has additional advantages, such as weight loss and hunger management, and it promotes heart health by lowering cholesterol. The device used to measure the level of ketone in the blood is known as blood ketone meters. One of the key reasons driving market expansion is the growing prevalence of diabetes. In 2020, according to the CDC, diabetes affected around 10.5 percent of the US population, with 26.9 million Americans diagnosed with the disease. According to the American Diabetes Association, about 210,000 Americans under the age of 20 were expected to be diagnosed with diabetes in 2018. The growth in diabetes among teenagers is expected to increase demand for blood ketone meters. Furthermore, product recalls on a regular basis hinder the market in forecasting years. Whereas, to hold a strong market position, many market players such as Abbott, Keto-Mojo, and EKF Diagnostics are concentrating on technologically improved blood ketone meters.


The main regions of Asia Pacific, North America, Europe, Latin America, and the Rest of the World are included in the geographical analysis of the worldwide Blood Ketone Meter market. In 2020, North America had the largest market share. Improved healthcare infrastructure and widespread use of blood ketone meters in the United States and Canada, particularly during the COVID-19 epidemic, are expected to drive market growth in North America. Government policies to encourage glucose and ketone monitoring are expected to boost market growth significantly. During the projection period, Europe is expected to grow at a significant rate. Diabetes is becoming more prevalent in Europe, impacting individuals of all ages. Diabetes is caused by a poor diet, lack of physical activity, and obesity. The rising number of diabetic patients is projected to boost regional market growth.

Major market player included in this report are:
Abbott
KETO-MOJO
ForaCare Inc.
Bruno Pharma
Care Touch
GlucoRx
Nova Diabetes Care
Trividia Health, Inc.
ACON Laboratories Inc.
Nipro Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Blood ketone Monitoring
Blood Glucose and Ketone Monitoring
Consumables
By Application:
Human
Veterinary
By End-use:
Hospitals
Diagnostic Centers
Homecare Settings
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Blood Ketone Meter Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors